We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+1.76%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$21.4B
AUM Growth
+$1.5B
Cap. Flow
+$1.66B
Cap. Flow %
7.75%
Top 10 Hldgs %
50.4%
Holding
201
New
31
Increased
27
Reduced
32
Closed
37

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$1.41B
2
CHTR icon
Charter Communications
CHTR
+$462M
3
CBRE icon
CBRE Group
CBRE
+$375M
4
SGEN
Seagen Inc. Common Stock
SGEN
+$314M
5
VMW
VMware, Inc
VMW
+$285M

Top Sells

Rank Stock Value
1
EFX icon
Equifax
EFX
+$249M
2
IQV icon
IQVIA
IQV
+$239M
3
BIIB icon
Biogen
BIIB
+$172M
4
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$130M
5
TMO icon
Thermo Fisher Scientific
TMO
+$105M

Sector Composition

Rank Sector Weight
1 Healthcare 31.13%
2 Technology 23.99%
3 Financials 9.09%
4 Communication Services 6.05%
5 Industrials 4.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
THC icon
51
Tenet Healthcare
THC
$22.6B
$67.9M 0.32%
1,030,000
+278,000
+37% +$20.8M
SIMO icon
52
Silicon Motion
SIMO
$8.76B
$53.6M 0.25%
1,045,000
+110,000
+12% +$6.26M
EVH icon
53
Evolent Health
EVH
$536M
$51.8M 0.24%
1,900,909
– –
DXCM icon
54
DexCom
DXCM
$34.8B
$50.8M 0.24%
+544,000
New +$61.3M
NBIX icon
55
Neurocrine Biosciences
NBIX
$15.5B
$50.4M 0.24%
+448,000
New +$47.2M
ROIV icon
56
Roivant Sciences
ROIV
$26.2B
$45M 0.21%
3,853,400
+1,498,400
+64% +$16.9M
MRTX
57
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$43.6M 0.2%
+1,001,000
New +$35.7M
HCA icon
58
HCA Healthcare
HCA
$92.9B
$42.9M 0.2%
174,400
-88,000
-34% -$24.1M
DEN
59
DELISTED
Denbury Inc.
DEN
$41.7M 0.19%
+425,000
New +$38.5M
SVRA icon
60
Savara
SVRA
$1.15B
$41.2M 0.19%
10,908,086
– –
SPLK
61
DELISTED
Splunk Inc
SPLK
$39.7M 0.19%
+271,625
New +$30.8M
AMED
62
DELISTED
Amedisys
AMED
$39.6M 0.18%
+424,000
New +$39.2M
IONS icon
63
Ionis Pharmaceuticals
IONS
$9.93B
$33M 0.15%
727,000
+722,000
+14,440% +$29.8M
CRL icon
64
Charles River Laboratories
CRL
$14.1B
$28.6M 0.13%
+146,000
New +$30M
OPCH icon
65
Option Care Health
OPCH
$3.55B
$27.9M 0.13%
862,000
-1,205,134
-58% -$40.6M
ENTA icon
66
Enanta Pharmaceuticals
ENTA
$392M
$20.9M 0.1%
1,875,000
– –
X
67
DELISTED
US Steel
X
$20.6M 0.1%
+635,000
New +$17.8M
MASI
68
DELISTED
Masimo
MASI
$20M 0.09%
227,649
-140,000
-38% -$16.3M
BHVN icon
69
Biohaven
BHVN
$2.09B
$19.5M 0.09%
750,000
– –
IMVT icon
70
Immunovant
IMVT
$9.16B
$19.3M 0.09%
+504,000
New +$11.4M
SEDA
71
DELISTED
SDCL EDGE Acquisition Corporation
SEDA
$18.4M 0.09%
1,732,500
– –
NATI
72
DELISTED
National Instruments Corp
NATI
$15.8M 0.07%
+265,000
New +$15.6M
AAC
73
DELISTED
Ares Acquisition Corporation
AAC
$15.3M 0.07%
1,425,000
– –
ZYME icon
74
Zymeworks
ZYME
$2.05B
$12.7M 0.06%
2,000,000
– –
ESTE
75
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
$12.5M 0.06%
+618,831
New +$10.8M
1 2
3
4 5

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q3 2023 Portfolio in Review

As of Q3 2023, Thomas Steyer held 201 positions worth $21.4B, up 7.5% from $19.9B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Thomas Steyer deployed $1.66B of net new capital in Q3 2023, opening 31 new positions and adding to 27 existing holdings. Its largest new stake was Charter Communications: 1,111,341 shares worth $489M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 35% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was IQVIA, an estimated $239M trimmed.

  • Thomas Steyer's largest Q3 2023 buy was Charter Communications: 1,111,341 shares worth $489M.
  • Thomas Steyer added most to Activision Blizzard in Q3 2023, an estimated $1.41B increase.
  • Thomas Steyer's biggest Q3 2023 reduction was IQVIA, cutting an estimated $239M.
  • Thomas Steyer fully exited Equifax in Q3 2023, selling an estimated $249M.
  • Thomas Steyer's ten largest holdings make up 50% of its $21.4B portfolio in Q3 2023.
  • Thomas Steyer opened 31 new positions and closed 37 in Q3 2023.
  • Thomas Steyer's portfolio value rose 7.5% quarter-over-quarter to $21.4B.

Based on Farallon Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.